Exosomal lncRNAs and cancer: connecting the missing links

Motivation: Extracellular vesicles (EVs), including exosomes and microvesicles, are potent and clinically valuable tools for early diagnosis, prognosis and potentially the targeted treatment of cancer. The content of EVs is closely related to the type and status of the EV‐secreting cell. Circulating exosomes are a source of stable RNAs including mRNAs, microRNAs and long non‐coding RNAs (lncRNAs). Results: This review outlines the links between EVs, lncRNAs and cancer. We highlight communication networks involving the tumor microenvironment, the immune system and metastasis. We show examples supporting the value of exosomal lncRNAs as cancer biomarkers and therapeutic targets. We demonstrate how a system biology approach can be used to model cell‐cell communication via exosomal lncRNAs and to simulate effects of therapeutic interventions. In addition, we introduce algorithms and bioinformatics resources for the discovery of tumor‐specific lncRNAs and tools that are applied to determine exosome content and lncRNA function. Finally, this review provides a comprehensive collection and guide to databases for exosomal lncRNAs. Supplementary information: Supplementary data are available at Bioinformatics online.

[1]  Eshel Ben-Jacob,et al.  Modeling putative therapeutic implications of exosome exchange between tumor and immune cells , 2014, Proceedings of the National Academy of Sciences.

[2]  Chunhe Li,et al.  Identifying the optimal anticancer targets from the landscape of a cancer-immunity interaction network. , 2017, Physical chemistry chemical physics : PCCP.

[3]  L-Q Wang,et al.  Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells. , 2016, European review for medical and pharmacological sciences.

[4]  Avner Friedman,et al.  The Role of Exosomes in Pancreatic Cancer Microenvironment , 2017, Bulletin of Mathematical Biology.

[5]  Jan Lötvall,et al.  EVpedia: A community web resource for prokaryotic and eukaryotic extracellular vesicles research. , 2015, Seminars in cell & developmental biology.

[6]  Wei Li,et al.  Extracellular vesicles-mediated noncoding RNAs transfer in cancer , 2017, Journal of Hematology & Oncology.

[7]  P. Altevogt,et al.  Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation , 2012, PLoS biology.

[8]  Olaf Wolkenhauer,et al.  Hybrid modeling of the crosstalk between signaling and transcriptional networks using ordinary differential equations and multi-valued logic. , 2014, Biochimica et biophysica acta.

[9]  Jintian Tang,et al.  Analysis of lncRNAs expression in UVB-induced stress responses of melanocytes. , 2016, Journal of dermatological science.

[10]  Tushar Patel,et al.  Involvement of Extracellular Vesicle Long Noncoding RNA (linc-VLDLR) in Tumor Cell Responses to Chemotherapy , 2014, Molecular Cancer Research.

[11]  Emre Özgür,et al.  Accumulation of GAS5 in exosomes is a marker of apoptosis induction. , 2017, Biomedical reports.

[12]  Claudia Berrondo,et al.  Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes , 2016, PloS one.

[13]  Wei Liang,et al.  Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression , 2017, Journal of Cancer Research and Clinical Oncology.

[14]  Giovanni Camussi,et al.  Role of extracellular RNA-carrying vesicles in cell differentiation and reprogramming , 2015, Stem Cell Research & Therapy.

[15]  Desi Shang,et al.  Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer. , 2015, Molecular bioSystems.

[16]  U. Gezer,et al.  Long non‐coding RNAs with low expression levels in cells are enriched in secreted exosomes , 2014, Cell biology international.

[17]  J. Hou,et al.  Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. , 2013, European journal of cancer.

[18]  Y. Shao,et al.  Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer , 2015, Tumor Biology.

[19]  Meg Duroux,et al.  A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.

[20]  S Hanash,et al.  Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  Anil K Sood,et al.  Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma , 2018, Cancer.

[22]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[23]  Wang Lq,et al.  Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells. , 2016 .

[24]  Guosong Jiang,et al.  LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2. , 2017, Cancer letters.

[25]  Rui Mao,et al.  LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR‐1236 in hepatocellular carcinoma cells , 2018, Life sciences.

[26]  Bing Chen,et al.  exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes , 2017, Nucleic Acids Res..

[27]  Ashish Kumar Agrawal,et al.  Exosomal formulation enhances therapeutic response of celastrol against lung cancer. , 2016, Experimental and molecular pathology.

[28]  Robert M Hoffman,et al.  Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation , 2017, Oncotarget.

[29]  Raghu Kalluri,et al.  Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer , 2017, Nature.

[30]  A. Krainer,et al.  Abstract PR11: Differentiation of mammary tumors and reduction in metastasis upon Malat1 LncRNA loss , 2016 .

[31]  M. Guan,et al.  Exosomal Long Noncoding RNAs are Differentially Expressed in the Cervicovaginal Lavage Samples of Cervical Cancer Patients , 2016, Journal of clinical laboratory analysis.

[32]  Y Liu,et al.  Glioma cells promote angiogenesis through the release of exosomes containing long non-coding RNA POU3F3. , 2017, European review for medical and pharmacological sciences.

[33]  Lei Dong,et al.  Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application as Biomarkers for Diagnosis of Colorectal Cancer , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[34]  Mohamed Abdouh,et al.  Exosomes isolated from cancer patients’ sera transfer malignant traits and confer the same phenotype of primary tumors to oncosuppressor-mutated cells , 2017, Journal of Experimental & Clinical Cancer Research.

[35]  Jing Bai,et al.  Identification of cancer-related lncRNAs through integrating genome, regulome and transcriptome features. , 2015, Molecular bioSystems.

[36]  G. Chrousos,et al.  Noncoding RNA Gas5 Is a Growth Arrest– and Starvation-Associated Repressor of the Glucocorticoid Receptor , 2010, Science Signaling.

[37]  Shivakumar Keerthikumar,et al.  ExoCarta: A Web-Based Compendium of Exosomal Cargo. , 2016, Journal of molecular biology.

[38]  Kazuyuki Takata,et al.  Effective internalization of U251-MG-secreted exosomes into cancer cells and characterization of their lipid components. , 2015, Biochemical and biophysical research communications.

[39]  Bo Zhang,et al.  Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2 , 2017, Oncology reports.

[40]  Peter P. Lee,et al.  Modeling Protective Anti-Tumor Immunity via Preventative Cancer Vaccines Using a Hybrid Agent-based and Delay Differential Equation Approach , 2012, PLoS Comput. Biol..

[41]  Ferran Reverter,et al.  Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features , 2016 .

[42]  Cecilia Clementi,et al.  Operating principles of Notch–Delta–Jagged module of cell–cell communication , 2015 .

[43]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[44]  R. Schiffelers,et al.  Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy , 2017, Gene Therapy.

[45]  Liuqing Yang,et al.  lncRNA Directs Cooperative Epigenetic Regulation Downstream of Chemokine Signals , 2014, Cell.

[46]  Howard Y. Chang,et al.  Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes , 2010, Science.

[47]  Giovanni Camussi,et al.  Cellular phenotype and extracellular vesicles: basic and clinical considerations. , 2014, Stem cells and development.

[48]  Alireza Ahadi,et al.  Long non-coding RNAs harboring miRNA seed regions are enriched in prostate cancer exosomes , 2016, Scientific Reports.

[49]  Jennifer C. Jones,et al.  Obstacles and opportunities in the functional analysis of extracellular vesicle RNA – an ISEV position paper , 2017, Journal of extracellular vesicles.

[50]  J. Rinn,et al.  Multiplexable, locus-specific targeting of long RNAs with CRISPR-Display , 2015, Nature Methods.

[51]  Alfredo Pulvirenti,et al.  miRandola 2017: a curated knowledge base of non-invasive biomarkers , 2017, Nucleic Acids Res..

[52]  Xiangxiang Liu,et al.  Exosomal lncRNA 91H is associated with poor development in colorectal cancer by modifying HNRNPK expression , 2018, Cancer Cell International.

[53]  J. Redzic,et al.  Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro. , 2014, Biochimica et biophysica acta.

[54]  Jiang Li,et al.  Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma , 2014, Oncotarget.

[55]  Simona Soverini,et al.  Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. , 2006, Blood.

[56]  Ping Zhang,et al.  Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer , 2018, OncoTargets and therapy.

[57]  Peng Wang,et al.  Lnc2Cancer: a manually curated database of experimentally supported lncRNAs associated with various human cancers , 2015, Nucleic Acids Res..

[58]  Kei-Hoi Cheung,et al.  Extending gene ontology in the context of extracellular RNA and vesicle communication , 2016, Journal of Biomedical Semantics.

[59]  Bronwen L. Aken,et al.  GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.

[60]  Sushmita Paul,et al.  Model-based genotype-phenotype mapping used to investigate gene signatures of immune sensitivity and resistance in melanoma micrometastasis , 2016, Scientific Reports.

[61]  C. Roberts,et al.  RNA trafficking by acute myelogenous leukemia exosomes. , 2013, Cancer research.

[62]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[63]  H. Ishwaran,et al.  Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways , 2014, Cell.

[64]  Pieter Vader,et al.  Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting , 2016, Journal of extracellular vesicles.

[65]  Kevin V. Morris,et al.  Extracellular vesicle associated long non-coding RNAs functionally enhance cell viability , 2016, Non-coding RNA research.

[66]  Fang Zhang,et al.  Targeting long non-coding RNA ASBEL with oligonucleotide antagonist for breast cancer therapy. , 2017, Biochemical and biophysical research communications.

[67]  Kei-Hoi Cheung,et al.  Extending gene ontology in the context of extracellular RNA and vesicle communication , 2016, Journal of biomedical semantics.

[68]  Xinghua Shi,et al.  A Network Based Method for Analysis of lncRNA-Disease Associations and Prediction of lncRNAs Implicated in Diseases , 2014, PloS one.

[69]  Yu Wang,et al.  Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer. , 2017, Biochemical and biophysical research communications.

[70]  Tommaso Lorenzi,et al.  Modelling the Immune Response to Cancer: An Individual-Based Approach Accounting for the Difference in Movement Between Inactive and Activated T Cells , 2018, Bulletin of mathematical biology.

[71]  T. Patel,et al.  Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer , 2014, FEBS open bio.

[72]  Tom Misteli,et al.  A BRCA1‐interacting lncRNA regulates homologous recombination , 2015, EMBO reports.

[73]  G. Vassalli,et al.  Exosomes: Therapy delivery tools and biomarkers of diseases , 2017, Pharmacology & therapeutics.

[74]  Fei Xing,et al.  Stromal cell extracellular vesicular cargo mediated regulation of breast cancer cell metastasis via ubiquitin conjugating enzyme E2 N pathway , 2017, Oncotarget.

[75]  Yangchao Chen,et al.  Targeting long non-coding RNAs in cancers: progress and prospects. , 2013, The international journal of biochemistry & cell biology.

[76]  Wolfram-Hubertus Zimmermann,et al.  Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin , 2018, Cancer biology & therapy.

[77]  Pedro Fonseca,et al.  A novel community driven software for functional enrichment analysis of extracellular vesicles data , 2017, Journal of extracellular vesicles.

[78]  Bin Li,et al.  Exploring functions of long noncoding RNAs across multiple cancers through co-expression network , 2017, Scientific Reports.

[79]  Yan Zhang,et al.  LincSNP 2.0: an updated database for linking disease-associated SNPs to human long non-coding RNAs and their TFBSs , 2016, Nucleic Acids Res..

[80]  Olaf Wolkenhauer,et al.  The RNA world in the 21st century - a systems approach to finding non-coding keys to clinical questions , 2016, Briefings Bioinform..

[81]  Wen-Lang Lin,et al.  Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer. , 2013, Genes & cancer.

[82]  Deepak Mittal,et al.  New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape. , 2014, Current opinion in immunology.

[83]  Liang Wenbo,et al.  Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape , 2017, Journal of The Royal Society Interface.

[84]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[85]  Qiong Zhang,et al.  lncRNASNP2: an updated database of functional SNPs and mutations in human and mouse lncRNAs , 2017, Nucleic Acids Res..

[86]  Jun Lu,et al.  The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer , 2016, Cell Death and Differentiation.

[87]  Yasutomo Yajima,et al.  Isolation of human salivary extracellular vesicles by iodixanol density gradient ultracentrifugation and their characterizations , 2016, Journal of extracellular vesicles.

[88]  K. Kodys,et al.  Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug‐induced, and inflammatory liver diseases , 2012, Hepatology.

[89]  Xing Chen,et al.  Novel human lncRNA-disease association inference based on lncRNA expression profiles , 2013, Bioinform..

[90]  Y. Wu,et al.  A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls , 2016, Oncogenesis.

[91]  Wei Chen,et al.  Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1 , 2017, Molecular Cancer.

[92]  K. Nephew,et al.  Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer , 2017, Scientific Reports.

[93]  Howard Y. Chang,et al.  NONCODING RNA: CRISPRi‐based genome‐scale identification of functional long noncoding RNA loci in human cells , 2017 .

[94]  Xiang Ying,et al.  Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA , 2017, Cancer Cell International.

[95]  Tushar Patel,et al.  Modulation of hypoxia-signaling pathways by extracellular linc-RoR , 2014, Journal of Cell Science.

[96]  Andreas Möller,et al.  Oncogenic transformation of lung cells results in distinct exosome protein profile similar to the cell of origin , 2017, Proteomics.

[97]  Hongwei Pan,et al.  Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer , 2016, Oncotarget.

[98]  Yutaka Saikawa,et al.  Interaction between the immune system and acute myeloid leukemia: A model incorporating promotion of regulatory T cell expansion by leukemic cells , 2018, Biosyst..

[99]  Zhijian Cai,et al.  Tumor-derived exosomes educate dendritic cells to promote tumor metastasis via HSP72/HSP105-TLR2/TLR4 pathway , 2017, Oncoimmunology.

[100]  Jin Ding,et al.  Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA. , 2016, Cancer cell.

[101]  Bruce Stillman,et al.  Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics. , 2007, Cancer cell.

[102]  Alissa M. Weaver,et al.  Extracellular Vesicles: Unique Intercellular Delivery Vehicles. , 2017, Trends in cell biology.

[103]  Dennis Shasha,et al.  miRò: a miRNA knowledge base , 2009, Database J. Biol. Databases Curation.

[104]  S. Srivastava,et al.  Prostate cancer: Diagnostic performance of the PCA3 urine test , 2011, Nature Reviews Urology.